FDA Inspection 1197976 — Abdoul Habib Beavogui, M.D.
The FDA completed an inspection of Abdoul Habib Beavogui, M.D. on Jan 13, 2023 in Conakry. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 13, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Conakry (Guinea)
Additional Details
Clinical Investigator (CI)